牛牛AI助理已提取核心訊息
Moderna, Inc. officer Shannon Thyme is set to sell 117 shares of the company's common stock on 03/04/2024, with an aggregate market value of $11,037.58. The shares were acquired on 03/01/2024 as part of a restricted stock vesting agreement with the issuer, Moderna, and were compensation for Thyme's role within the company. This transaction follows a series of sales over the past three months, where Thyme sold a total of 1,344 shares, amounting to gross proceeds of $116,692.11.
Moderna, Inc. officer Shannon Thyme is set to sell 117 shares of the company's common stock on 03/04/2024, with an aggregate market value of $11,037.58. The shares were acquired on 03/01/2024 as part of a restricted stock vesting agreement with the issuer, Moderna, and were compensation for Thyme's role within the company. This transaction follows a series of sales over the past three months, where Thyme sold a total of 1,344 shares, amounting to gross proceeds of $116,692.11.
Moderna, Inc.高管Shannon Thyme定於2024年4月3日出售該公司117股普通股，總市值爲11,037.58美元。作爲與發行人Moderna簽訂的限制性股票歸屬協議的一部分，這些股票於2024年1月3日被收購，是對百里香在公司中的職責的補償。該交易是在過去三個月進行了一系列銷售之後進行的，百里香共出售了1,344股股票，總收益爲116,692.11美元。
Moderna, Inc.高管Shannon Thyme定於2024年4月3日出售該公司117股普通股，總市值爲11,037.58美元。作爲與發行人Moderna簽訂的限制性股票歸屬協議的一部分，這些股票於2024年1月3日被收購，是對百里香在公司中的職責的補償。該交易是在過去三個月進行了一系列銷售之後進行的，百里香共出售了1,344股股票，總收益爲116,692.11美元。
有用
沒用